{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T13:22:54Z","timestamp":1768915374645,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T00:00:00Z","timestamp":1530748800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1208\/s12249-018-1115-z","type":"journal-article","created":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T18:22:47Z","timestamp":1530814967000},"page":"2710-2718","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Hydroxypropyl-\u03b2-Cyclodextrin and \u03b2-Cyclodextrin as Tablet Fillers for Direct Compression"],"prefix":"10.1208","volume":"19","author":[{"given":"Jaime","family":"Concei\u00e7\u00e3o","sequence":"first","affiliation":[]},{"given":"Oluwatomide","family":"Adeoye","sequence":"additional","affiliation":[]},{"given":"Helena Maria","family":"Cabral-Marques","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Manuel","family":"Sousa Lobo","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,7,5]]},"reference":[{"key":"1115_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1381612824666171218125431","volume":"24","author":"J Concei\u00e7\u00e3o","year":"2018","unstructured":"Concei\u00e7\u00e3o J, Adeoye O, Cabral-Marques HM, Lobo JMS. Cyclodextrins as drug carriers in pharmaceutical technology: the state of the art. Curr Pharm Des. 2018;24:1\u201329.","journal-title":"Curr Pharm Des"},{"issue":"1\u20132","key":"1115_CR2","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ijpharm.2017.11.018","volume":"535","author":"P Jansook","year":"2018","unstructured":"Jansook P, Ogawa N, Loftsson T. Cyclodextrins: structure, physicochemical properties and pharmaceutical applications. Int J Pharm. 2018;535(1\u20132):272\u201384.","journal-title":"Int J Pharm"},{"key":"1115_CR3","doi-asserted-by":"crossref","unstructured":"Sal\u00fastio PJ, Pontes P, Conduto C, Sanches I, Carvalho C, Arrais J, et al. Advanced technologies for oral controlled release: cyclodextrins for oral controlled release. AAPS PharmSciTech. 2011;12(4):1276\u201392.","DOI":"10.1208\/s12249-011-9690-2"},{"issue":"2","key":"1115_CR4","doi-asserted-by":"publisher","first-page":"E329","DOI":"10.1208\/pt060243","volume":"6","author":"R Challa","year":"2005","unstructured":"Challa R, Ahuja A, Ali J, Khar RK. Cyclodextrins in drug delivery: an updated review. AAPS PharmSciTech. 2005;6(2):E329\u201357.","journal-title":"AAPS PharmSciTech"},{"key":"1115_CR5","doi-asserted-by":"crossref","unstructured":"Adeoye O, Cabral-Marques H. Cyclodextrin nanosystems in oral drug delivery: a mini review. Int J Pharm. 2017;531(2):521\u201331.","DOI":"10.1016\/j.ijpharm.2017.04.050"},{"key":"1115_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.carbpol.2015.04.048","volume":"129","author":"R Gharib","year":"2015","unstructured":"Gharib R, Greige-Gerges H, Fourmentin S, Charcosset C, Auezova L. Liposomes incorporating cyclodextrin-drug inclusion complexes: current state of knowledge. Carbohydr Polym. 2015;129:175\u201386.","journal-title":"Carbohydr Polym"},{"key":"1115_CR7","doi-asserted-by":"publisher","unstructured":"di Cagno MP. The potential of cyclodextrins as novel active pharmaceutical ingredients: a short overview. Molecules. 2016;22(1). https:\/\/doi.org\/10.3390\/molecules22010001 .","DOI":"10.3390\/molecules22010001"},{"issue":"40","key":"1115_CR8","doi-asserted-by":"publisher","first-page":"5877","DOI":"10.2174\/1381612821666151008125117","volume":"21","author":"S Mangal","year":"2015","unstructured":"Mangal S, Meiser F, Morton D, Larson I. Particle engineering of excipients for direct compression: understanding the role of material properties. Curr Pharm Des. 2015;21(40):5877\u201389.","journal-title":"Curr Pharm Des"},{"issue":"6","key":"1115_CR9","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.drudis.2018.04.009","volume":"23","author":"J Concei\u00e7\u00e3o","year":"2018","unstructured":"Concei\u00e7\u00e3o J, Adeoye O, Cabral-Marques HM, Sousa Lobo JM. Cyclodextrins as excipients in tablet formulations. Drug Discov Today. 2018;23(6):1274\u201384.","journal-title":"Drug Discov Today"},{"issue":"1","key":"1115_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3109\/10837450.2014.954728","volume":"20","author":"M Leane","year":"2015","unstructured":"Leane M, Pitt K, Reynolds G. A proposal for a drug product manufacturing classification system (MCS) for oral solid dosage forms. Pharm Dev Technol. 2015;20(1):12\u201321.","journal-title":"Pharm Dev Technol"},{"issue":"1\u20132","key":"1115_CR11","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ijpharm.2017.01.030","volume":"519","author":"Z Li","year":"2017","unstructured":"Li Z, Lin X, Shen L, Hong Y, Feng Y. Composite particles based on particle engineering for direct compaction. Int J Pharm. 2017;519(1\u20132):272\u201386.","journal-title":"Int J Pharm"},{"key":"1115_CR12","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.powtec.2017.12.021","volume":"326","author":"M Dra\u0161kovi\u0107","year":"2018","unstructured":"Dra\u0161kovi\u0107 M, Djuri\u0161 J, Ibri\u0107 S, Paroj\u010di\u0107 J. Functionality and performance evaluation of directly compressible co-processed excipients based on dynamic compaction analysis and percolation theory. Powder Technol. 2018;326:292\u2013301.","journal-title":"Powder Technol"},{"issue":"1","key":"1115_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v23.i1.10","volume":"23","author":"S Patel","year":"2006","unstructured":"Patel S, Kaushal AM, Bansal AK. Compression physics in the formulation development of tablets. Crit Rev Ther Drug Carrier Syst. 2006;23(1):1\u201365.","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"issue":"10","key":"1115_CR14","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.3109\/03639045.2011.645833","volume":"38","author":"J Rojas","year":"2012","unstructured":"Rojas J, Buckner I, Kumar V. Co-proccessed excipients with enhanced direct compression functionality for improved tableting performance. Drug Dev Ind Pharm. 2012;38(10):1159\u201370.","journal-title":"Drug Dev Ind Pharm"},{"key":"1115_CR15","unstructured":"Cyclodextrins used as excipients. London: European medicines agency (EMA), Committee for Human Medicinal Products (CHMP); 2017."},{"issue":"1","key":"1115_CR16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1021\/mp800128y","volume":"6","author":"I Kovacevi\u0107","year":"2009","unstructured":"Kovacevi\u0107 I, Parojci\u0107 J, Homsek I, Tubi\u0107-Grozdanis M, Langguth P. Justification of biowaiver for carbamazepine, a low soluble high permeable compound, in solid dosage forms based on IVIVC and gastrointestinal simulation. Mol Pharm. 2009;6(1):40\u20137.","journal-title":"Mol Pharm"},{"key":"1115_CR17","unstructured":"European Pharmacopoeia (Ph. Eur.). 9th edition. Strasbourg: European Directorate for the Quality of Medicines and HealthCare (EDQM); 2017."},{"key":"1115_CR18","first-page":"163","volume":"72","author":"RL Carr","year":"1965","unstructured":"Carr RL. Evaluating flow properties of solids. Chem Eng. 1965;72:163\u20138.","journal-title":"Chem Eng"},{"key":"1115_CR19","first-page":"13","volume":"8","author":"RL Carr","year":"1976","unstructured":"Carr RL. Powder and granule properties and mechanics. Chem Eng. 1976;8:13\u201388.","journal-title":"Chem Eng"},{"key":"1115_CR20","first-page":"7","volume":"3","author":"H Hausner","year":"1967","unstructured":"Hausner H. Friction conditions in a mass of metal powder. Int J Powder Metall. 1967;3:7\u201313.","journal-title":"Int J Powder Metall"},{"key":"1115_CR21","first-page":"7","volume":"22","author":"A Stamm","year":"1976","unstructured":"Stamm A, Mathis C. Verpressbarkeit von festen Hilfsstoffen f\u00fcr Direkttablettierung. Acta Pharm Technol. 1976;22:7\u201316.","journal-title":"Acta Pharm Technol"},{"key":"1115_CR22","first-page":"17","volume":"2","author":"TM Jones","year":"1981","unstructured":"Jones TM. The physicochemical properties of starting materials used in tablet formulation. Int J Pharm Tech Prod Manuf. 1981;2:17\u201324.","journal-title":"Int J Pharm Tech Prod Manuf"},{"issue":"5","key":"1115_CR23","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/jps.2600590523","volume":"59","author":"JT Fell","year":"1970","unstructured":"Fell JT, Newton JM. Determination of tablet strength by the diametral-compression test. J Pharm Sci. 1970;59(5):688\u201391.","journal-title":"J Pharm Sci"},{"key":"1115_CR24","unstructured":"Portuguese Pharmacopoeia 9.0. Lisbon: INFARMED, Health Ministry; 2008."},{"issue":"2","key":"1115_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","volume":"13","author":"P Costa","year":"2001","unstructured":"Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13(2):123\u201333.","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"1115_CR26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1742-7843.2009.00518.x","volume":"106","author":"JA Morais","year":"2010","unstructured":"Morais JA, Lobato MDR. The new European medicines agency guideline on the investigation of bioequivalence. Basic Clin Pharmacol Toxicol. 2010;106(3):221\u20135.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1","key":"1115_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpb.2010.01.007","volume":"75","author":"J Wang","year":"2010","unstructured":"Wang J, Wen H, Desai D. Lubrication in tablet formulations. Eur J Pharm Biopharm. 2010;75(1):1\u201315.","journal-title":"Eur J Pharm Biopharm"},{"key":"1115_CR28","volume-title":"Aulton's pharmaceutics: the design and manufacture of medicines","author":"ME Aulton","year":"2013","unstructured":"Aulton ME, Taylor KMG. Aulton's pharmaceutics: the design and manufacture of medicines. 4th ed. London: Churchill Livingstone; 2013.","edition":"4"},{"issue":"2","key":"1115_CR29","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1248\/cpb.32.670","volume":"32","author":"E Fenyvesi","year":"1984","unstructured":"Fenyvesi E, Takayama K, Szejtli J, Nagai T. Evaluation of cyclodextrin polymer as an additive for furosemide tablet. Chem Pharm Bull (Tokyo). 1984;32(2):670\u20137.","journal-title":"Chem Pharm Bull (Tokyo)."},{"issue":"2","key":"1115_CR30","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1248\/cpb.32.665","volume":"32","author":"E Fenyvesi","year":"1984","unstructured":"Fenyvesi E, Shirakura O, Szejtli J, Nagai T. Properties of cyclodextrin polymer as a tabletting aid. Chem Pharm Bull (Tokyo). 1984;32(2):665\u20139.","journal-title":"Chem Pharm Bull (Tokyo)."},{"issue":"4","key":"1115_CR31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.17219\/pim\/30770","volume":"44","author":"\u0141 Zimmer","year":"2014","unstructured":"Zimmer \u0141, Kasperek R, Poleszak E. Application of \u03b2-cyclodextrin in the formulation of ODT tablets containing ibuprofen. Polim Med. 2014;44(4):231\u20135.","journal-title":"Polim Med"},{"issue":"4","key":"1115_CR32","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1208\/s12249-010-9541-6","volume":"11","author":"SG Late","year":"2010","unstructured":"Late SG, Banga AK. Response surface methodology to optimize novel fast disintegrating tablets using \u03b2 cyclodextrin as diluent. AAPS PharmSciTech. 2010;11(4):1627\u201335.","journal-title":"AAPS PharmSciTech"},{"issue":"11","key":"1115_CR33","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1248\/cpb.57.1206","volume":"57","author":"K Motoyama","year":"2009","unstructured":"Motoyama K, Nagatomo K, Abd Elazim SO, Hirayama F, Uekama K, Arima H. Potential use of 2-hydroxypropyl-beta-cyclodextrin for preparation of orally disintegrating tablets containing dl-alpha-tocopheryl acetate, an oily drug. Chem Pharm Bull (Tokyo). 2009;57(11):1206\u201312.","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"1115_CR34","doi-asserted-by":"crossref","unstructured":"Garcia-Fernandez MJ, Tabary N, Chai F, Cazaux F, Blanchemain N, Flament MP, et al. New multifunctional pharmaceutical excipient in tablet formulation based on citric acid-cyclodextrin polymer. Int J Pharm. 2016;511(2):913\u201320.","DOI":"10.1016\/j.ijpharm.2016.07.059"},{"issue":"40","key":"1115_CR35","doi-asserted-by":"publisher","first-page":"5751","DOI":"10.2174\/1381612821666151008125852","volume":"21","author":"G Tan","year":"2015","unstructured":"Tan G, Morton DA, Larson I. On the methods to measure powder flow. Curr Pharm Des. 2015;21(40):5751\u201365.","journal-title":"Curr Pharm Des"},{"issue":"8","key":"1115_CR36","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3109\/10837450.2013.840843","volume":"19","author":"O Adeoye","year":"2014","unstructured":"Adeoye O, Alebiowu G. Flow, packing and compaction properties of novel coprocessed multifunctional directly compressible excipients prepared from tapioca starch and mannitol. Pharm Dev Technol. 2014;19(8):901\u201310.","journal-title":"Pharm Dev Technol"},{"issue":"3","key":"1115_CR37","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1208\/s12249-013-9994-5","volume":"14","author":"JP Sousa e Silva","year":"2013","unstructured":"Sousa e Silva JP, Splendor D, Gon\u00e7alves IMB, Costa P, Sousa Lobo JM. Note on the measurement of bulk density and tapped density of powders according to the European pharmacopeia. AAPS PharmSciTech. 2013;14(3):1098\u2013100.","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"1115_CR38","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1208\/s12249-013-0036-0","volume":"15","author":"A Crouter","year":"2014","unstructured":"Crouter A, Briens L. The effect of moisture on the flowability of pharmaceutical excipients. AAPS PharmSciTech. 2014;15(1):65\u201374.","journal-title":"AAPS PharmSciTech"},{"issue":"1\u20132","key":"1115_CR39","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ijpharm.2008.06.023","volume":"362","author":"LX Liu","year":"2008","unstructured":"Liu LX, Marziano I, Bentham AC, Litster JD, White ET, Howes T. Effect of particle properties on the flowability of ibuprofen powders. Int J Pharm. 2008;362(1\u20132):109\u201317.","journal-title":"Int J Pharm"},{"key":"1115_CR40","first-page":"111","volume":"66","author":"J Concei\u00e7\u00e3o","year":"2016","unstructured":"Concei\u00e7\u00e3o J, Teixeira C, Sousa G, Sim\u00f5es AM, Amorim A, S\u00e1 B, et al. Tablet machine instrumentation: influence of lubricants on the lubrication efficiency and compaction profiles. Arh farm. 2016;66:111\u20132.","journal-title":"Arh farm"},{"key":"1115_CR41","unstructured":"Concei\u00e7\u00e3o J, Sousa G, Teixeira C, Sim\u00f5es AM, S\u00e1 B, Sousa Lobo JM. Influence of lubricants on tabletting and drug release characteristics. In: 10th world meeting on pharmaceutics, biopharmaceutics and pharmaceutical technology. Glasgow: APV, APGI and A.D.R.I.T.E.L.F; 2016."},{"key":"1115_CR42","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.powtec.2011.12.060","volume":"238","author":"KG Pitt","year":"2013","unstructured":"Pitt KG, Heasley MG. Determination of the tensile strength of elongated tablets. Powder Technol. 2013;238:169\u201375.","journal-title":"Powder Technol"},{"issue":"2","key":"1115_CR43","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ejpb.2004.03.011","volume":"58","author":"E Doelker","year":"2004","unstructured":"Doelker E, Massuelle D. Benefits of die-wall instrumentation for research and development in tabletting. Eur J Pharm Biopharm. 2004;58(2):427\u201344.","journal-title":"Eur J Pharm Biopharm"},{"issue":"5","key":"1115_CR44","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1007\/s11095-017-2129-z","volume":"34","author":"D Markl","year":"2017","unstructured":"Markl D, Zeitler JA. A review of disintegration mechanisms and measurement techniques. Pharm Res. 2017;34(5):890\u2013917.","journal-title":"Pharm Res"},{"issue":"9","key":"1115_CR45","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1016\/j.xphs.2015.12.019","volume":"105","author":"PM Desai","year":"2016","unstructured":"Desai PM, Liew CV, Heng PWS. Review of disintegrants and the disintegration phenomena. J Pharm Sci. 2016;105(9):2545\u201355.","journal-title":"J Pharm Sci"},{"issue":"2","key":"1115_CR46","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3109\/10837459609029890","volume":"1","author":"F Ferrari","year":"1996","unstructured":"Ferrari F, Bertoni M, Bonferoni CM, Rossi S, Caramella C, Bolhuis GK. Dissolution enhancement of an insoluble drug by physical mixture with a superdisintegrant: optimization with a simplex lattice design. Pharm Dev Technol. 1996;1(2):159\u201364.","journal-title":"Pharm Dev Technol"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-018-1115-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-018-1115-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-018-1115-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T16:08:27Z","timestamp":1751731707000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-018-1115-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,5]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["1115"],"URL":"https:\/\/doi.org\/10.1208\/s12249-018-1115-z","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,5]]},"assertion":[{"value":"12 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}